Back
Speaker illustration

Miss Ana Belen Salido Medina

Instituto de Investigacion Sanitaria Valdecilla (IDIVAL), Santander (Spain)

Presentations Articles

Activation of bone morphogenetic protein type 1A receptors (BMPR1A) by THR184 halts the progression of the left ventricular remodelling under pressure overload

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Drugs, Drug Targets

Session: Moderated poster 4 AWARD

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources